Targeting of keloid with TRAIL and TRAIL-R2/DR5-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting of keloid with TRAIL and TRAIL-R2/DR5

Published:2020-01-20 Issue:8 Volume:32 Page:957-964
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Sun Pengfei¹,Hu Zhensheng²,Pan Bo³,Lu Xiaosheng⁴

Affiliation:

1. Department of Plastic Surgery, Zibo Central Hospital, Zibo, China

2. Department of Plastic Surgery, Qilu Hospital of Shandong University, Jinan, China

3. Department of Plastic Surgery, Plastic Surgery Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China

4. Department of Plastic Surgery, Affiliated Hospital of Weifang Medical University, Weifang, China

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2020.1714541

Reference82 articles.

1. The use of chemotherapeutics for the treatment of keloid scars

2. From genetics to epigenetics: new insights into keloid scarring

3. Three-dimensional poly lactic-co-glycolic acid scaffold containing autologous platelet-rich plasma supports keloid fibroblast growth and contributes to keloid formation in a nude mouse model

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of keloid by 32P isotope radiotherapy through suppressing TGF-β/Smad signaling pathway;Aging;2023-10-31

2. Serum TRAIL predicts severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study;Internal and Emergency Medicine;2022-10-14

3. Prevention of scar hyperplasia in the skin by conotoxin: A prospective review;Journal of Cosmetic Dermatology;2020-10-17

4. Chest X-ray findings monitoring COVID-19 disease course and severity;Egyptian Journal of Radiology and Nuclear Medicine;2020-09-22

5. COVID‐19: Herd immunity and convalescent plasma transfer therapy;Journal of Medical Virology;2020-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3